Aldeyra Therapeutics (ALDX) Tops Q1 EPS by 6c
Tweet
Share
E-mailGet Alerts ALDX Hot Sheet
Join SI Premium – FREE
Aldeyra Therapeutics (NASDAQ: ALDX) reported Q1 EPS of ($0.32), $0.06 better than the analyst estimate of ($0.38).
For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Jack Henry (JKHY) Tops Q4 EPS by 13c
- Evolution Petroleum launches stock offering to fund Permian Basin deal
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
